These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 25069089)
1. Effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of Alexander disease. Cotrina ML; Chen M; Han X; Iliff J; Ren Z; Sun W; Hagemann T; Goldman J; Messing A; Nedergaard M Brain Res; 2014 Sep; 1582():211-9. PubMed ID: 25069089 [TBL] [Abstract][Full Text] [Related]
3. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Hagemann TL; Boelens WC; Wawrousek EF; Messing A Hum Mol Genet; 2009 Apr; 18(7):1190-9. PubMed ID: 19129171 [TBL] [Abstract][Full Text] [Related]
4. STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease. Hagemann TL; Coyne S; Levin A; Wang L; Feany MB; Messing A Cells; 2023 Mar; 12(7):. PubMed ID: 37048051 [TBL] [Abstract][Full Text] [Related]
5. Metabolic Enzyme Alterations and Astrocyte Dysfunction in a Murine Model of Alexander Disease With Severe Reactive Gliosis. Heaven MR; Herren AW; Flint DL; Pacheco NL; Li J; Tang A; Khan F; Goldman JE; Phinney BS; Olsen ML Mol Cell Proteomics; 2022 Jan; 21(1):100180. PubMed ID: 34808356 [TBL] [Abstract][Full Text] [Related]
6. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. Hagemann TL; Connor JX; Messing A J Neurosci; 2006 Oct; 26(43):11162-73. PubMed ID: 17065456 [TBL] [Abstract][Full Text] [Related]
7. Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival. Hagemann TL; Jobe EM; Messing A PLoS One; 2012; 7(5):e37304. PubMed ID: 22693571 [TBL] [Abstract][Full Text] [Related]
8. Alexander disease: an astrocytopathy that produces a leukodystrophy. Sosunov A; Olabarria M; Goldman JE Brain Pathol; 2018 May; 28(3):388-398. PubMed ID: 29740945 [TBL] [Abstract][Full Text] [Related]
9. Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease. Minkel HR; Anwer TZ; Arps KM; Brenner M; Olsen ML Glia; 2015 Dec; 63(12):2285-97. PubMed ID: 26190408 [TBL] [Abstract][Full Text] [Related]
10. Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease. Pekny T; Faiz M; Wilhelmsson U; Curtis MA; Matej R; Skalli O; Pekny M APMIS; 2014 Jan; 122(1):76-80. PubMed ID: 23594359 [TBL] [Abstract][Full Text] [Related]
11. Alexander disease: putative mechanisms of an astrocytic encephalopathy. Mignot C; Boespflug-Tanguy O; Gelot A; Dautigny A; Pham-Dinh D; Rodriguez D Cell Mol Life Sci; 2004 Feb; 61(3):369-85. PubMed ID: 14770299 [TBL] [Abstract][Full Text] [Related]
12. Astrocyte pathology in Alexander disease causes a marked inflammatory environment. Olabarria M; Putilina M; Riemer EC; Goldman JE Acta Neuropathol; 2015 Oct; 130(4):469-86. PubMed ID: 26296699 [TBL] [Abstract][Full Text] [Related]
13. Aberrant astrocyte Ca Saito K; Shigetomi E; Yasuda R; Sato R; Nakano M; Tashiro K; Tanaka KF; Ikenaka K; Mikoshiba K; Mizuta I; Yoshida T; Nakagawa M; Mizuno T; Koizumi S Glia; 2018 May; 66(5):1053-1067. PubMed ID: 29383757 [TBL] [Abstract][Full Text] [Related]
14. Glial fibrillary acidic protein is pathologically modified in Alexander disease. Lin NH; Jian WS; Snider N; Perng MD J Biol Chem; 2024 Jul; 300(7):107402. PubMed ID: 38782207 [TBL] [Abstract][Full Text] [Related]
15. GFAP: functional implications gleaned from studies of genetically engineered mice. Messing A; Brenner M Glia; 2003 Jul; 43(1):87-90. PubMed ID: 12761871 [TBL] [Abstract][Full Text] [Related]
16. Vimentin and GFAP responses in astrocytes after contusion trauma to the murine brain. Ekmark-Lewén S; Lewén A; Israelsson C; Li GL; Farooque M; Olsson Y; Ebendal T; Hillered L Restor Neurol Neurosci; 2010; 28(3):311-21. PubMed ID: 20479526 [TBL] [Abstract][Full Text] [Related]
17. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance. Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771 [TBL] [Abstract][Full Text] [Related]
18. The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander disease. Sosunov AA; McKhann GM; Goldman JE Acta Neuropathol Commun; 2017 Mar; 5(1):27. PubMed ID: 28359321 [TBL] [Abstract][Full Text] [Related]
19. Regional difference of reactive astrogliosis following traumatic brain injury revealed by hGFAP-GFP transgenic mice. Kim WR; Kim JY; Moon Y; Kim HJ; Kim H; Sun W Neurosci Lett; 2012 Apr; 513(2):155-9. PubMed ID: 22343312 [TBL] [Abstract][Full Text] [Related]
20. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. Kamphuis W; Mamber C; Moeton M; Kooijman L; Sluijs JA; Jansen AH; Verveer M; de Groot LR; Smith VD; Rangarajan S; Rodríguez JJ; Orre M; Hol EM PLoS One; 2012; 7(8):e42823. PubMed ID: 22912745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]